What is the best probiotic to prevent vulvovaginal candidiasis (VVC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no evidence to support the use of probiotics in preventing yeast infections, and therefore, no specific probiotic can be recommended for this purpose. According to the most recent and highest quality study, 1, no evidence supports the use of alternative treatments, including probiotics, for the prevention of vulvovaginal candidiasis. The study emphasizes that azole antifungals remain the treatment of choice for uncomplicated vulvovaginal candidiasis.

When considering prevention and treatment options, it's essential to focus on evidence-based approaches. The 2022 study 1 provides the most current guidance, highlighting the importance of diagnosis through yeast culture and the effectiveness of azole antifungals.

Key points to consider:

  • Diagnosis should be confirmed through yeast culture or newer molecular assays.
  • Azole antifungals are the preferred treatment for uncomplicated vulvovaginal candidiasis.
  • For recurrent infections, maintenance therapy with fluconazole or other antifungals may be necessary.
  • There is no evidence to support the use of probiotics or other alternative treatments for preventing or treating yeast infections.

Given the lack of evidence supporting the use of probiotics for yeast infection prevention, the most effective approach is to follow evidence-based treatment guidelines [ 1 ], which do not include probiotic supplementation.

From the Research

Probiotics for Preventing Yeast Infections

  • The use of probiotics to prevent yeast infections, specifically vulvovaginal candidiasis, has been studied, but more research is needed to clarify their role 2.
  • Some probiotic strains, such as Lactobacillus and Bifidobacterium species, have been proposed to have beneficial effects on the gastrointestinal tract and potentially on vaginal health 3.
  • Saccharomyces boulardii, a yeast probiotic, has been found to be effective in preventing and treating various forms of diarrhea, including antibiotic-associated diarrhea and Clostridium difficile infection 4.
  • A meta-analysis of probiotics for the prevention of traveler's diarrhea found that several probiotics, including Saccharomyces boulardii and a mixture of Lactobacillus acidophilus and Bifidobacterium bifidum, had significant efficacy in preventing the disease 5.
  • A recent study found that the probiotic strains Bifidobacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum, and Saccharomyces boulardii regulated wound healing and chemokine responses in human intestinal subepithelial myofibroblasts, suggesting potential benefits for mucosal immunity 6.

Specific Probiotic Strains

  • Lactobacillus acidophilus and Bifidobacterium bifidum have been found to have significant efficacy in preventing traveler's diarrhea 5.
  • Saccharomyces boulardii has been found to be effective in preventing and treating various forms of diarrhea, including antibiotic-associated diarrhea and Clostridium difficile infection 4.
  • Bifidobacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum, and Saccharomyces boulardii have been found to regulate wound healing and chemokine responses in human intestinal subepithelial myofibroblasts 6.

Considerations

  • Probiotic benefits associated with one species or strain do not necessarily hold true for others 2.
  • The minimum number of microorganisms that must be ingested to obtain a beneficial effect is not established, but a probiotic should typically contain several billion microorganisms to increase the chance of adequate gut colonization 2.
  • Probiotics are generally considered safe and well-tolerated, but should be used cautiously in patients who are critically ill or severely immunocompromised 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Probiotics.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

Research

Lactic acid bacteria as probiotics.

Current issues in intestinal microbiology, 2006

Research

Review article: yeast as probiotics -- Saccharomyces boulardii.

Alimentary pharmacology & therapeutics, 2007

Research

Meta-analysis of probiotics for the prevention of traveler's diarrhea.

Travel medicine and infectious disease, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.